Biologics in Achilles tendon healing and repair: a review

被引：40
作者：
Shapiro E. [1 ]
Grande D. [1 ]
Drakos M. [1 ]
机构：
[1] Orthopedics Department, Feinstein Institute for Medical Research, 350 Community Dr, Manhasset, 11030, NY
来源：
Current Reviews in Musculoskeletal Medicine | 2015年 / 8卷 / 1期
关键词：
Achilles; Biologics; Bone marrow aspirate; Bone morphogenetic protein; Growth factor; Platelet-rich plasma; Scaffold; Stem cells;
D O I：
10.1007/s12178-015-9257-z
中图分类号：
学科分类号：
摘要：
Injuries of the Achilles tendon are relatively common with potentially devastating outcomes. Healing Achilles tendons form a fibrovascular scar resulting in a tendon which may be mechanically weaker than the native tendon. The resulting strength deficit causes a high risk for reinjury and other complications. Treatments using biologics aim to restore the normal properties of the native tendon and reduce the risk of rerupture and maximize tendon function. The purpose of this review was to summarize the current findings of various therapies using biologics in an attempt to improve the prognosis of Achilles tendon ruptures and tendinopathies. A PubMed search was performed using specific search terms. The search was open for original manuscripts and review papers limited to publication within the last 10 years. From these searches, papers were included in the review if they investigated the effects of biological augmentation on Achilles tendon repair or healing. Platelet-rich plasma may assist in the healing process of Achilles tendon ruptures, while the evidence to support its use in the treatment of chronic Achilles tendinopathies remains insufficient. The use of growth factors such as hepatocyte growth factor, recombinant human platelet-derived growth factor-BB, interleukin-6, and transforming growth factor beta as well as several bone morphogenetic proteins have shown promising results for Achilles tendon repair. In vitro and preclinical studies have indicated the potential effectiveness of bone marrow aspirate as well. Stem cells also have positive effects on Achilles tendon healing, particularly during the early phases. Polyhydroxyalkanoates (PHA), decellularized tendon tissue, and porcine small intestinal submucosa (SIS) are biomaterials which have shown promising results as scaffolds used in Achilles tendon repair. The application of biological augmentation techniques in Achilles tendon repair appears promising; however, several techniques require further investigation to evaluate their clinical application. © 2015, Springer Science+Business Media New York.
引用
收藏
页码：9 / 17
页数：8
相关论文
共 82 条
[41]  
Kraus T.M., Et al., Stem cells and basic fibroblast growth factor failed to improve tendon healing: an in vivo study using lentiviral gene transfer in a rat model, J Bone Joint Surg Am, 96, 9, pp. 761-769, (2014)
[42]  
Lee D.K., Achilles tendon repair with acellular tissue graft augmentation in neglected ruptures, J Foot Ankle Surg, 46, 6, pp. 451-455, (2007)
[43]  
Lee D.K., A preliminary study on the effects of acellular tissue graft augmentation in acute Achilles tendon ruptures, J Foot Ankle Surg, 47, 1, pp. 8-12, (2008)
[44]  
Lohan A., Et al., Human hamstring tenocytes survive when seeded into a decellularized porcine Achilles tendon extracellular matrix, Connect Tissue Res, 54, 4-5, pp. 305-312, (2013)
[45]  
Lyras D.N., Et al., The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing, Foot Ankle Int, 30, 11, pp. 1101-1106, (2009)
[46]  
Majewski M., Et al., Ex vivo adenoviral transfer of bone morphogenetic protein 12 (BMP-12) cDNA improves Achilles tendon healing in a rat model, Gene Ther, 15, 16, pp. 1139-1146, (2008)
[47]  
Majewski M., Et al., Improvement of tendon repair using muscle grafts transduced with TGF-beta1 cDNA, Eur Cell Mater, 23, pp. 94-101, (2012)
[48]  
Mikic B., Et al., Achilles tendon characterization in GDF-7 deficient mice, J Orthop Res, 24, 4, pp. 831-841, (2006)
[49]  
Monto R.R., Platelet rich plasma treatment for chronic Achilles tendinosis, Foot Ankle Int, 33, 5, pp. 379-385, (2012)
[50]  
Moraes V.Y., Et al., Platelet-rich therapies for musculoskeletal soft tissue injuries, Cochrane Database Syst Rev, 4, (2014)
123456789